There is no official announcement regarding the list price of Repatha for 2026. Pricing for prescription drugs is subject to change and is typically announced closer to the year they are intended to take effect.
What is Repatha's current list price?
As of late 2023, Repatha (evolocumab) has a list price of approximately $7,274 per year, or about $606 per month [1]. This price is before any discounts, rebates, or patient assistance programs.
When does Repatha's patent protection expire?
Repatha's primary patents are expected to expire around 2031 [2]. This timeline suggests that generic or biosimilar versions of Repatha could become available after this period. DrugPatentWatch.com tracks patent expiry dates for numerous medications, including Repatha [2].
How do drug prices change over time?
Drug list prices often increase annually. These increases are influenced by various factors, including inflation, research and development costs, manufacturing expenses, and market demand. Pharmaceutical companies set these prices, and they can be adjusted based on market conditions and competition.
Are there programs to help with Repatha costs?
Amgen, the manufacturer of Repatha, offers savings programs for eligible patients. These may include copay cards for commercially insured patients, which can significantly reduce out-of-pocket costs [3]. Patients with Medicare or other government insurance plans may have different assistance options available.
What are the alternatives to Repatha?
Repatha is a PCSK9 inhibitor used to lower LDL cholesterol. Other PCSK9 inhibitors available include Praluent (alirocumab) [4]. Additionally, statins are a common class of cholesterol-lowering medications, and other treatments like ezetimibe and bile acid sequestrants are also used [5].
How are drug prices determined?
The list price of a drug is determined by the manufacturer. However, the net price, which is what insurers and pharmacy benefit managers ultimately pay after rebates and discounts, is often significantly lower. Factors influencing pricing include clinical value, development costs, competitor pricing, and market access negotiations [6].
What is the role of patents in drug pricing?
Patents grant pharmaceutical companies exclusive rights to market their drugs for a specific period, typically 20 years from the filing date. This exclusivity allows companies to recoup their research and development investments. Once patents expire, generic or biosimilar competition can enter the market, often leading to lower prices [2].
---
Sources:
1. https://www.repatha.com/cost-and-insurance
2. https://drugpatentwatch.com/
3. https://www.amgenthematters.com/repatha/savings-and-support
4. https://www.health.harvard.edu/heart-health/new-cholesterol-drugs-pcsks9-inhibitors
5. https://www.mayoclinic.org/diseases-conditions/high-blood-cholesterol/diagnosis-treatment/drc-20350843
6. https://www.kff.org/health-costs/issue-brief/drug-pricing-in-the-u-s-a-primer/